Current and novel treatment options for actinic keratosis

Joseph L Jorizzo1

  • 1Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157, USA. jjorizzo@wfubmc.edu

Insights

Topical treatments are gaining interest for managing actinic keratosis (AK), a growing skin condition. These therapies effectively treat subclinical AK and offer a valuable option for healthcare providers.

Area of Science:

  • Dermatology
  • Oncology

Background:

  • Actinic keratosis (AK) presents a significant global health challenge, primarily affecting sun-exposed skin.
  • Current management involves ablative and topical treatments, with a growing focus on topical options due to their ability to address subclinical lesions in photodamaged skin.

Purpose of the Study:

  • To review the efficacy and safety data of various topical therapies for actinic keratosis.
  • To highlight the role of topical treatments in managing AK, particularly in the context of photodamage.

Main Methods:

  • Literature review of key data on topical treatments for AK.
  • Discussion of specific agents including 5-fluorouracil, photodynamic therapy, diclofenac sodium gel, and imiquimod cream.
  • Focus on imiquimod 5% cream, approved for facial and scalp AK.

Main Results:

  • Topical therapies demonstrate efficacy in managing actinic keratosis.
  • Imiquimod 5% cream is highlighted for its use in treating facial and scalp AK.
  • Both monotherapy and adjunctive use of topical agents are effective.

Conclusions:

  • Topical therapies are a promising and effective approach for managing actinic keratosis.
  • These treatments are crucial for addressing subclinical disease and offer a valuable addition to the clinician's toolkit.

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...